Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Adverse pharmacokinetic interactions between illicit substances and clinical drugs.

Abbott KL, Flannery PC, Gill KS, Boothe DM, Dhanasekaran M, Mani S, Pondugula SR.

Drug Metab Rev. 2019 Dec 11:1-22. doi: 10.1080/03602532.2019.1697283. [Epub ahead of print]

PMID:
31826670
2.

Correlation of PPM1A Downregulation with CYP3A4 Repression in the Tumor Liver Tissue of Hepatocellular Carcinoma Patients.

Flannery PC, Abbott KL, Pondugula SR.

Eur J Drug Metab Pharmacokinet. 2019 Dec 2. doi: 10.1007/s13318-019-00595-3. [Epub ahead of print]

PMID:
31792727
3.

Preclinical analysis of MTOR complex 1/2 inhibition in diffuse intrinsic pontine glioma.

Flannery PC, DeSisto JA, Amani V, Venkataraman S, Lemma RT, Prince EW, Donson A, Moroze EE, Hoffman L, Levy JMM, Foreman N, Vibhakar R, Green AL.

Oncol Rep. 2018 Feb;39(2):455-464. doi: 10.3892/or.2017.6122. Epub 2017 Nov 29.

4.

Pyrimido[1″,2″:1,5]pyrazolo[3,4-b]quinolines: Novel compounds that reverse ABCG2-mediated resistance in cancer cells.

Karthikeyan C, Malla R, Ashby CR Jr, Amawi H, Abbott KL, Moore J, Chen J, Balch C, Lee C, Flannery PC, Trivedi P, Faridi JS, Pondugula SR, Tiwari AK.

Cancer Lett. 2016 Jun 28;376(1):118-26. doi: 10.1016/j.canlet.2016.03.030. Epub 2016 Mar 21.

PMID:
27012188
5.

Mg2+/Mn2+-dependent phosphatase 1A is involved in regulating pregnane X receptor-mediated cytochrome p450 3A4 gene expression.

Pondugula SR, Flannery PC, Apte U, Babu JR, Geetha T, Rege SD, Chen T, Abbott KL.

Drug Metab Dispos. 2015 Mar;43(3):385-91. doi: 10.1124/dmd.114.062083. Epub 2015 Jan 5.

PMID:
25561723
6.

Diindolylmethane, a naturally occurring compound, induces CYP3A4 and MDR1 gene expression by activating human PXR.

Pondugula SR, Flannery PC, Abbott KL, Coleman ES, Mani S, Samuel T, Xie W.

Toxicol Lett. 2015 Feb 3;232(3):580-9. doi: 10.1016/j.toxlet.2014.12.015. Epub 2014 Dec 24.

Supplemental Content

Loading ...
Support Center